An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...

A recent award ceremony which is actually significant revealed about the best companies right now existing in the country US ...

The poultry medicine/pharmaceuticals market valued at US$ 4.73 billion in 2023, is forecasted to grow at a robust CAGR of 5.9%, reaching US$ ...

Global Capability Centers — offshore units that handle the parent’s business processes — accounted for over a third of the ...

Asia Pacific pharmaceutical manufacturing industry market will grow by 11.3% annually with a total addressable market cap of $57.26 billion over 2023-2032. The growth is driven by the increased drug ...

Market Structure ? Growth Drivers ? Restraints and Challenges ? Emerging Product Trends & Market Opportunities ? Porter?s Fiver Forces The trend and outlook of global market is forecast in optimistic, ...

But some political forces—and Ghanaians, in fact—choose to dismiss this as an Oliver asking for more, Yet, this does not take ...

Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...

Plaque Psoriasis BURLINGAME, CA, UNITED STATES, January 27, 2025 /EINPresswire / -- The worldwide Plaque Psoriasis <a target=_blank href=h ...